Literature DB >> 33407484

Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy.

Hyemoon Chung1, Yoonjung Kim2, Chul Hwan Park3, In-Soo Kim4, Jong-Youn Kim4, Pil-Ki Min4, Young Won Yoon4, Tae Hoon Kim4, Byoung Kwon Lee4, Bum-Kee Hong4, Se-Joong Rim4, Hyuck Moon Kwon4, Kyung-A Lee5, Eui-Young Choi6.   

Abstract

BACKGROUND: Left atrial (LA) enlargement and dysfunction are related to clinical course in patients with hypertrophic cardiomyopathy (HCM). We aimed to investigate genetic contribution to LA structural and functional remodeling.
METHODS: Two hundred twelve patients were consecutively enrolled, and echocardiography and extensive genetic analysis were performed. Cardiac magnetic resonance (CMR) was performed in 135 patients. Echocardiography was also performed in controls (n = 30).
RESULTS: Patients with HCM had lower late-diastolic mitral annular velocity (a') and higher LA volume index (LAVI) than controls. Patients with pathogenic or likely pathogenic sarcomere gene mutations (PSM, n = 67, 32%) had higher LAVI and lower CMR-derived LA total emptying fraction (37.0 ± 18.5 vs. 44.2 ± 12.4%, p = 0.025). In patients without AF (n = 187), the PSM had lower a' (6.9 ± 2.0 vs. 7.8 ± 1.9 cm/s, p = 0.004) than others. The PSM had higher prevalence and amount of late gadolinium enhancement (LGE) in the left ventricle (LV). In multivariate analysis, PSM was significantly related to lower a' independent of E/e', LV mass index, and LAVI. However, the relation significantly attenuated after adjustment for the extent of LGE in the LV, suggesting common myopathy in the LV and LA. In addition, PSM was significantly related to lower LA total emptying fraction independent of age, E/e', s', LV ejection fraction, LV myocardial global longitudinal strain and %LGE mass.
CONCLUSIONS: PSM was related to LA dysfunction independent of LV filling pressure and LAVI, suggesting its contribution to atrial myopathy in HCM.

Entities:  

Keywords:  Genetic mutation; Hypertrophic cardiomyopathy; Left atrial function

Year:  2021        PMID: 33407484     DOI: 10.1186/s12947-020-00233-y

Source DB:  PubMed          Journal:  Cardiovasc Ultrasound        ISSN: 1476-7120            Impact factor:   2.062


  17 in total

1.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

2.  Left Atrium as an Active Component of the Pathophysiology in HCM.

Authors:  Toshiyuki Ko
Journal:  Int Heart J       Date:  2018       Impact factor: 1.862

3.  Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation.

Authors:  Philippe Debonnaire; Emer Joyce; Yasmine Hiemstra; Bart J Mertens; Douwe E Atsma; Martin J Schalij; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-02

4.  Hypertrophic Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging.

Authors:  Sanjay Sivalokanathan; Tarek Zghaib; Gabriela V Greenland; Nestor Vasquez; Shibani M Kudchadkar; Effrosyni Kontari; Dai-Yin Lu; Ketty Dolores-Cerna; Rob J van der Geest; Ihab R Kamel; Jeffrey E Olgin; Theodore P Abraham; Saman Nazarian; Stefan L Zimmerman; M Roselle Abraham
Journal:  JACC Clin Electrophysiol       Date:  2018-12-26

5.  Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy.

Authors:  Hyemoon Chung; Yoonjung Kim; Sun-Mi Cho; Ho-Joon Lee; Chul-Hwan Park; Jong-Youn Kim; Sang-Hak Lee; Pil-Ki Min; Young Won Yoon; Byoung Kwon Lee; Woo-Shik Kim; Bum-Kee Hong; Tae Hoon Kim; Se-Joong Rim; Hyuck Moon Kwon; Eui-Young Choi; Kyung-A Lee
Journal:  Mitochondrion       Date:  2020-05-04       Impact factor: 4.160

6.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

7.  Mitochondrial cardiomyopathies: how to identify candidate pathogenic mutations by mitochondrial DNA sequencing, MITOMASTER and phylogeny.

Authors:  Michael V Zaragoza; Martin C Brandon; Marta Diegoli; Eloisa Arbustini; Douglas C Wallace
Journal:  Eur J Hum Genet       Date:  2010-10-27       Impact factor: 4.246

8.  mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences.

Authors:  Max Ingman; Ulf Gyllensten
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

9.  MITOMAP: a human mitochondrial genome database--2004 update.

Authors:  Marty C Brandon; Marie T Lott; Kevin Cuong Nguyen; Syawal Spolim; Shamkant B Navathe; Pierre Baldi; Douglas C Wallace
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

10.  Simultaneous Whole Mitochondrial Genome Sequencing with Short Overlapping Amplicons Suitable for Degraded DNA Using the Ion Torrent Personal Genome Machine.

Authors:  Lakshmi Chaitanya; Arwin Ralf; Mannis van Oven; Tomasz Kupiec; Joseph Chang; Robert Lagacé; Manfred Kayser
Journal:  Hum Mutat       Date:  2015-10-08       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.